Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 375 of 1631 entries
View as:

A Study to Compare the Effect of Transipeg 2.95 g or Forlax Junior 4 g in Children With Constipation

Phase: N/A Priority: Normal
NCT ID: NCT01810653 Org: User:
Start: 04/30/06 End: 12/31/08 Due: 12/31/09

A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion)

Phase: N/A Priority: Normal
NCT ID: NCT05850520 Org: User:
Start: 05/15/23 End: 05/27/25 Due: 05/27/26

Efficacy and Tolerability of Angeliq in Thai Women

Phase: N/A Priority: Normal
NCT ID: NCT00185328 Org: User:
Start: 09/30/05 End: 12/31/06 Due: 12/31/07

Sun Protection Factor (SPF) Assay

Phase: N/A Priority: Normal
NCT ID: NCT02857725 Org: User:
Start: 05/18/15 End: 06/09/15 Due: 06/09/16

FC Patch Low: Metabolism Study

Phase: N/A Priority: Normal
NCT ID: NCT00933179 Org: User:
Start: 06/30/09 End: 09/30/10 Due: 09/30/11

Special Drug Use Investigation of Ciproxan Injection in Pediatrics

Phase: N/A Priority: Normal
NCT ID: NCT02555059 Org: User:
Start: 07/15/16 End: 06/13/19 Due: 06/13/20

Bioequivalence Study for Acarbose/Metformin FDC

Phase: N/A Priority: Normal
NCT ID: NCT04065581 Org: User:
Start: 10/14/19 End: 03/06/20 Due: 03/06/21

Xarelto on Prevention of Stroke and Non-Central Nervous Systemic Embolism in Renally Impaired Korean Patients With Non-valvular Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT03746301 Org: User:
Start: 12/03/18 End: 12/15/21 Due: 12/15/22

Renal Impairment Study

Phase: N/A Priority: Normal
NCT ID: NCT03402438 Org: User:
Start: 02/12/18 End: 03/19/19 Due: 03/19/20

Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM)

Phase: N/A Priority: Normal
NCT ID: NCT00692770 Org: User:
Start: 08/15/08 End: 11/28/14 Due: 11/28/15

Gadobutrol Enhanced MRA of the Supra-aortic Vessels

Phase: N/A Priority: Normal
NCT ID: NCT01344447 Org: User:
Start: 05/12/11 End: 05/28/14 Due: 05/28/15

Regulatory Post Marketing Surveillance Study on Nexavar®

Phase: N/A Priority: Normal
NCT ID: NCT01012011 Org: User:
Start: 09/30/09 End: 08/31/15 Due: 08/31/16

Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)

Phase: N/A Priority: Normal
NCT ID: NCT00751205 Org: User:
Start: 08/31/08 End: 08/31/10 Due: 08/31/11

Study on the Safety of BAY 63-2521, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given as a Single Oral Dose of 1 mg Tablet in Participants With Impaired Liver Function and Healthy Participants Matched for Age-, Gender-, and Weight

Phase: N/A Priority: Normal
NCT ID: NCT04366622 Org: User:
Start: 04/14/10 End: 09/15/11 Due: 09/15/12

Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT01069328 Org: User:
Start: 07/31/06 End: 10/31/11 Due: 10/31/12

The Safety and toleRability of UltraviSt in Patients Undergoing Cardiac CaTheterization (TRUST)

Phase: N/A Priority: Normal
NCT ID: NCT01206257 Org: User:
Start: 08/31/10 End: 09/30/11 Due: 09/30/12

Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Factor Xa Non-vitamin-K Oral Anticoagulants (NOACs) vs. Phenprocoumon

Phase: N/A Priority: Normal
NCT ID: NCT03563937 Org: User:
Start: 06/15/18 End: 12/10/19 Due: 12/10/20

PMS Study Ultravist-IMAGE, IoproMide (UltrAvist) to Gain Further Information on Tolerability and Safety in X-ray Examination

Phase: N/A Priority: Normal
NCT ID: NCT00876083 Org: User:
Start: 03/31/08 End: 09/30/09 Due: 09/30/10

Clinical Outcomes Among Non-valvular Atrial Fibrillation Patients With Renal Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT03359876 Org: User:
Start: 12/01/17 End: 03/29/19 Due: 03/29/20

A Study to Observe Treatment Patterns in Patients in Colombia Who Have Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT05036967 Org: User:
Start: 08/01/21 End: 11/16/22 Due: 11/16/23

A Trial to Learn How a New Liquid Form of Rivaroxaban Behaves and How Safe it is Compared to the Current Tablet Form of Rivaroxaban in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT04720092 Org: User:
Start: 07/05/17 End: 10/27/17 Due: 10/27/18

Study on the Safety of the Approved Product Empedic L Cream During Its Routine Use (Active Ingredient is Clotrimazole 1%)

Phase: N/A Priority: Normal
NCT ID: NCT03599323 Org: User:
Start: 07/10/18 End: 09/03/21 Due: 09/03/22

Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women

Phase: N/A Priority: Normal
NCT ID: NCT02403401 Org: User:
Start: 05/15/15 End: 07/07/16 Due: 07/07/17

Treatment of Vasomotor Symptoms in Korean Post Menopausal Women

Phase: N/A Priority: Normal
NCT ID: NCT00651599 Org: User:
Start: 07/31/04 End: 05/31/05 Due: 05/31/06

Japanese BAY1000394 Monotherapy Phase I Study

Phase: N/A Priority: Normal
NCT ID: NCT02047890 Org: User:
Start: 05/19/14 End: 07/19/18 Due: 07/19/19